×
ADVERTISEMENT

ewing sarcoma

2 Drug Classes May Be Synergistic in Treating Ewing Sarcoma

For children with Ewing sarcoma, a combination of two different classes of drugs may work synergistically to turn ...

AUGUST 22, 2019

FDA Grants Orphan Drug Designation to Ganitumab for Ewing Sarcoma

The drug was granted  orphan drug designation for the treatment of patients with Ewing sarcoma.

APRIL 11, 2017

BuMel May Offer Benefit in High-Risk Ewing Sarcoma

Chicago—Busulfan and melphalan in combination (BuMel) may represent a potential new standard treatment for ...

SEPTEMBER 12, 2016

Hypoxia and “Microenvironmental Stresses” Can Prompt Metastasis of Ewing Sarcoma

Depriving Ewing sarcoma cells of blood or oxygen leads to cell migration and increased invasiveness, investigators ...

AUGUST 30, 2016

First Epidemiological Data on Chest Wall Ewing Sarcoma Released

Researchers have published what is the largest database analysis to date of patients with chest wall Ewing sarcoma

AUGUST 30, 2016

Drug Combo An ‘Excellent’ Option for Some Ewing Sarcoma Patients

Combination temozolomide and irinotecan was called an “excellent option” for patients with Ewing ...

JULY 18, 2016

Treatment Does Not Affect Control Of Femur Tumors in Ewing Sarcoma

There are no significant differences in disease outcomes when clinicians use surgery alone, radiotherapy alone or a ...

JUNE 20, 2016

Pregnancy Plasma Protein May Be Therapeutic Target for Ewing Sarcoma

The five-year overall survival for pediatric patients with relapsed or metastatic Ewing sarcoma is less than 20%, ...

APRIL 23, 2016

Data Shed Light on Course of Ewing Sarcoma Survivors

Long-term survivors of Ewing sarcoma are at “considerable” risk for late relapse and death, but ...

MARCH 21, 2016

Load more